HYPERTENSION AS A CAUSATIVE DIAGNOSIS OF PATIENTS ENTERING END-STAGE RENAL-DISEASE PROGRAMS IN THE UNITED-STATES FROM 1980 TO 1986

被引:52
作者
BLYTHE, WB
MADDUX, FW
机构
[1] Division of Nephrology, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
关键词
TREATMENT OF HYPERTENSION; END-STAGE RENAL DISEASE;
D O I
10.1016/S0272-6386(12)80287-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Treatment of hypertension has decreased the incidence of stroke and congestive heart failure consequential to hypertension. To determine whether the incidence of hypertension as a causative diagnosis of end-stage renal disease (ESRD) is also decreasing, we examined the records of the Health Care Financing Administration (HCFA) from 1980 to 1986 regarding the causative diagnoses of patients entering ESRD programs. We found that the incidence of patients entering ESRD programs increased during the study period. Hypertension as a causative diagnosis was a constant proportion of the increase. The greatest increase occurred in patients age 55 or more years. This was strikingly true of black patients. We conclude that there has not been a decrease in the incidence of hypertension as a causative diagnosis for patients entering ESRD programs and that this may be a reflection that treatment of hypertension does not prevent the development of ESRD in some patients. We propose that prospective studies be undertaken to determine whether this is the case. © 1991, National Kidney Foundation, Inc.. All rights reserved.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 25 条
[1]  
[Anonymous], 1982, Lancet, V1, P185
[2]  
DUSTAN HP, 1987, AM J CARDIOL, V60, P731
[3]   TARGET ORGAN DAMAGE IN BLACK HYPERTENSIVES [J].
ENTWISLE, G ;
APOSTOLIDES, AY ;
HEBEL, JR ;
HENDERSON, MM .
CIRCULATION, 1977, 55 (05) :792-796
[4]   RENAL VASCULATURE IN ESSENTIAL HYPERTENSION - RACIAL-DIFFERENCES [J].
LEVY, SB ;
TALNER, LB ;
COEL, MN ;
HOLLE, R ;
STONE, RA .
ANNALS OF INTERNAL MEDICINE, 1978, 88 (01) :12-16
[5]  
MAVER SM, 1984, J CLIN INVEST, V74, P1143
[6]   RACIAL-DIFFERENCES IN THE INCIDENCE OF HYPERTENSIVE END-STAGE RENAL-DISEASE (ESRD) ARE NOT ENTIRELY EXPLAINED BY DIFFERENCES IN THE PREVALENCE OF HYPERTENSION [J].
MCCLELLAN, W ;
TUTTLE, E ;
ISSA, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 12 (04) :285-290
[7]   LONG-TERM ANTIHYPERTENSIVE TREATMENT INHIBITING PROGRESSION OF DIABETIC NEPHROPATHY [J].
MOGENSEN, CE .
BRITISH MEDICAL JOURNAL, 1982, 285 (6343) :685-688
[8]  
Parving H H, 1988, J Diabet Complications, V2, P92, DOI 10.1016/0891-6632(88)90010-4
[9]   DIABETIC NEPHROPATHY AND ARTERIAL-HYPERTENSION - THE EFFECT OF ANTIHYPERTENSIVE TREATMENT [J].
PARVING, HH ;
ANDERSEN, AR ;
SMIDT, UM ;
CHRISTIANSEN, JS ;
OXENBOLL, B ;
SVENDSEN, PA .
DIABETES, 1983, 32 :83-87
[10]   RENAL-INSUFFICIENCY IN TREATED ESSENTIAL-HYPERTENSION [J].
ROSTAND, SG ;
BROWN, G ;
KIRK, KA ;
RUTSKY, EA ;
DUSTAN, HP .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (11) :684-688